Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Bishop

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 24, 2019
HR-pQCT Measures of Bone Microarchitecture Predict Fracture: Systematic Review and Meta-AnalysisNicholas Mikolajewicz, Nick Bishop, Andrew J Burghardt, et al.
Nature Genetics|July 17, 2007
Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKLCristina Sobacchi, Annalisa Frattini, Matteo M Guerrini, et al.
Lancet (London, England)|August 10, 2013
Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trialNick Bishop, Silvano Adami, S Faisal Ahmed, et al.
The New England Journal of Medicine|March 9, 2012
Enzyme-replacement therapy in life-threatening hypophosphatasiaMichael P Whyte, Cheryl R Greenberg, Nada J Salman, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 24, 2019
HR-pQCT Measures of Bone Microarchitecture Predict Fracture: Systematic Review and Meta-AnalysisNicholas Mikolajewicz, Nick Bishop, Andrew J Burghardt, et al.
Nature Genetics|July 17, 2007
Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKLCristina Sobacchi, Annalisa Frattini, Matteo M Guerrini, et al.
Lancet (London, England)|August 10, 2013
Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trialNick Bishop, Silvano Adami, S Faisal Ahmed, et al.
The New England Journal of Medicine|March 9, 2012
Enzyme-replacement therapy in life-threatening hypophosphatasiaMichael P Whyte, Cheryl R Greenberg, Nada J Salman, et al.
Pageof 6